BeiGene’s Brukinsa Set To Take On Imbruvica With CLL Approval

 
• By Joseph Haas
  
BeiGene's Brukinsa adds US indication for chronic lymphocytic leukemia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip